Skip Navigation

Cardiovascular Research 2002 55(4):787-798; doi:10.1016/S0008-6363(02)00493-5
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Aoyama, T.
Right arrow Articles by Fujiwara, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoyama, T.
Right arrow Articles by Fujiwara, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Molecular mechanisms of non-apoptosis by Fas stimulation alone versus apoptosis with an additional actinomycin D in cultured cardiomyocytes

Takuma Aoyamaa, Genzou Takemuraa, Rumi Maruyamaa, Ken-ichiro Kosaib, Tomoyuki Takahashib, Masahiko Kodaa, Kenji Hayakawaa, Yukinori Kawasea, Shinya Minatoguchia and Hisayoshi Fujiwaraa,*

aSecond Department of Internal Medicine, Gifu University School of Medicine, 40 Tsukasa-Machi, Gifu 500-8705, Japan
bDepartment of Cardiovascular Regeneration Science, Gifu University School of Medicine, 40 Tsukasa-Machi, Gifu 500-8705, Japan

* Corresponding author. Tel.: +81-58-267-2607; fax: +81-58-267-2933 gifuim-gif{at}umin.ac.jp

Objective: In cultured cardiomyocytes, apoptosis is induced not by Fas stimulation, a popular inducer of apoptosis, but by an additional treatment with actinomycin D (AD), a transcription inhibitor, although the mechanism is unknown. Our hypothesis is that Fas stimulation not only activates pro-apoptotic signals but also may inhibit some of them, and this inhibition is blocked by AD. Methods: Cultured neonatal mouse cardiomyocytes were treated with agonistic anti-Fas antibody (FA), AD, or both (FA+AD). In this system, apoptotic signals related to Fas-induced apoptotic pathways were examined by RT-PCR and immunoblotting. In addition, antisense oligonucleotide (AS) studies were carried out. Results: The treatment with FA+AD induced up-regulation of Fas, activation of c-Jun N-terminal kinase (JNK), which is one of the key molecules of the alternate pathway of Fas-induced apoptosis, up-regulation of Bax, up-regulation and activation of caspase-3, activation of caspase-3-dependent DNase (CAD), and final DNA fragmentation and apoptotic morphologies in cardiomyocytes. FA alone or AD alone did not affect any part of the above pathway. However, mRNA of mitogen-activated protein kinase phosphatase-1 (MKP-1), an inactivator of JNK, was up-regulated by FA alone, but not by FA+AD or AD alone. Pretreatment with AS against MKP-1 induced apoptosis in FA alone-treated cardiomyocytes, whereas AS against JNK1 prevented apoptosis induced by FA+AD. On the other hand, FA+AD did not result in the activation of either caspase-8, one of the key molecules of the classic pathway in Fas-induced apoptosis, p38 MAPK, or extracellular signal-regulated kinase (ERK). Conclusions: Cardiomyocyte apoptosis by FA+AD depends on the alternate pathway through the JNK, Bax and caspase-3, and CAD-dependent pathways including a positive feedback mechanism of Fas up-regulation. The molecular mechanism that prevents Fas stimulation alone from inducing apoptosis involves up-regulation of MKP-1, an inhibitor of JNK; this up-regulation is inhibited by AD.

KEYWORDS Apoptosis; Cell culture/isolation; Gene expression; Myocytes; Signal transduction


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Okada, G. Takemura, K.-i. Kosai, A. Tsujimoto, M. Esaki, T. Takahashi, S. Nagano, H. Kanamori, S. Miyata, Y. Li, et al.
Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H616 - H626.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Esaki, G. Takemura, K.-i. Kosai, T. Takahashi, S. Miyata, L. Li, K. Goto, R. Maruyama, H. Okada, H. Kanamori, et al.
Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1048 - H1057.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Mayorga, N. Bahi, M. Ballester, J. X. Comella, and D. Sanchis
Bcl-2 Is a Key Factor for Cardiac Fibroblast Resistance to Programmed Cell Death
J. Biol. Chem., August 13, 2004; 279(33): 34882 - 34889.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Bernstein, C. M. Payne, K. Kunke, C. L. Crowley-Weber, C. N. Waltmire, K. Dvorakova, H. Holubec, C. Bernstein, R. R. Vaillancourt, D. A. Raynes, et al.
A proteomic study of resistance to deoxycholate-induced apoptosis
Carcinogenesis, May 1, 2004; 25(5): 681 - 692.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Pervin, R. Singh, W. A. Freije, and G. Chaudhuri
MKP-1-Induced Dephosphorylation of Extracellular Signal-Regulated Kinase Is Essential for Triggering Nitric Oxide-Induced Apoptosis in Human Breast Cancer Cell Lines: Implications in Breast Cancer
Cancer Res., December 15, 2003; 63(24): 8853 - 8860.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.